Polycyclic compound acting as kinase inhibitor
AssigneeHangzhou Innogate Pharma Co., Ltd.
InventorsHancheng Zhang, Xin Cheng, Wei Jia, Congcong Cai
Life of this patent
Estimating the term…
Abstract
The present invention provides a class of compounds containing tricyclic heteroaryl groups. Specifically, the present invention provides compounds of the structure represented by the following formula (I) (the definition of each group is described in the specification), pharmaceutical compositions containing the compounds of formula (I), as well as optical isomers, pharmaceutical acceptable salts, prodrugs, deuterated derivatives, hydrates, solvates, etc. The compounds of formula (I) can effectively inhibit protein kinases including CDK and/or TRK, thereby playing a role in the treatment of various tumors and related disease.
Claims20
A compound of formula (I), or optical isomers, pharmaceutically acceptable salts, prodrugs, deuterated forms, hydrates, or solvates thereof:
- wherein:
- “*” indicates a chiral center;
- X is hydrogen, deuterium, halogen, C1-4 alkyl, OR1, NR1R2, or N(R1)C(O)R3;
- each R is independently hydrogen or C1-4 alkyl;
- or when two R are simultaneously attached to one carbon atom, the two R and the carbon atom to which they are attached optionally form a carbonyl group (C═O);
- G is NRf, O, S, S(O), S(O)2 or CRgRg;
- p is 0, 1, 2 or 3;
- m and n are each independently 0, 1, 2 or 3;
- with the proviso that m and n cannot simultaneously be 0;
- R1 and R2 are each independently hydrogen or C1-4 alkyl;
- R3 is C1-4 alkyl, C2-4 alkenyl or C2-4 alkynyl;
- Rf is hydrogen, C1-4 alkyl, C1-4 haloalkyl, cyano substituted C1-4 alkyl, C2-4 alkenyl, C2-4 alkynyl, C3-8 cycloalkyl, 4- to 8-membered heterocyclyl, aryl, heteroaryl, C(O)R4, C(O)OR1, C(O)NR1R2, S(O)2R4, or S(O)2NR1R2;
- each Rg is each independently selected from the group consisting of hydrogen, halogen, and C1-4 alkyl;
- or two Rg together with the carbon atom to which they are attached form a carbonyl group (C═O);
- or two Rg together with the carbon atom to which they attached form a 3- to 8-membered cyclic structure which optionally comprises 0, 1 or 2 heteroatoms selected from N, O or S;
- R4 is C1-4 alkyl, C2-4 alkenyl, C2-4 alkynyl, C3-8 cycloalkyl, 4- to 8-membered heterocyclic group, aryl, or heteroaryl;
- wherein each of the above alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl and heteroaryl is optionally and independently substituted by 1 to 3 substituents which are each independently selected from the group consisting of halogen, C1-4 alkyl, C1-4 haloalkyl, C2-4 alkenyl, C2-4 alkynyl, C3-8 cycloalkyl, 3- to 8-membered heterocyclic group, aryl, heteroaryl, CN, NO2, OR1, SR1, NR1R2, C(O)R4, C(O)OR1, C(O)NR1R2, NR1C(O)R4, and S(O)2R4;
- the R1, R2 and R4 are defined as above;
- unless otherwise specified, the aryl is aromatic groups having 6 to 12 carbon atoms;
- the heteroaryl is 5- to 15-membered heteroaromatic groups;
- and the cyclic structure is saturated or unsaturated cyclic groups with or without heteroatoms.
Dependencies are inferred from the claim text.